PATIENT-FIRST AI
PATIENT-FIRST AI
PATIENT-FIRST AI
PRECISION TARGET
PRECISION DESIGN
PRECISION EXPERIMENT
PRECISION MEDICINE
PRESENTATIONS
PUBLICATIONS
PIPELINE
INVESTORS & MEDIA
INVESTORS & MEDIA
INVESTORS & MEDIA
PRESS RELEASES
EVENTS & PRESENTATIONS
FINANCIALS & FILINGS
CAREERS
CONTACT
Exscientia is now Recursion
Stay up to date at
www.Recursion.com
Posted: October 31, 2023
Back to AI-driven Approach to the Discovery of Novel Mpro Inhibitors with High Pan-coronavirus Activity